Making conjoint fit for pharma

At Inpharmation, we developed the Pharma-Specific Conjoint platform specifically to address the challenges of reliability and sample size in pharma market research. We transform preference shares into more accurate market shares before finally incorporating the additional jigsaw pieces to generate pharma-validated, forecast-ready market shares. This series of papers will show you the key steps to adapting conjoint to make it fit for pharma.

Back to White Papers

Download the document by filling in the form:

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top